(Q42611726)

English

Insulin Detemir Is Characterized by a Consistent Pharmacokinetic Profile Across Age-Groups in Children, Adolescents, and Adults With Type 1 Diabetes

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 November 2017

Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes (English)

1 reference

Europe PubMed Central

3 November 2017

Insulin Detemir Is Characterized by a Consistent Pharmacokinetic Profile Across Age-Groups in Children, Adolescents, and Adults With Type 1 Diabetes (English)

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin detemir

1 reference

based on heuristic

inferred from title

internal medicine

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Thomas Danne

1

1 reference

Europe PubMed Central

3 November 2017

Kerstin Lüpke

2

1 reference

Europe PubMed Central

3 November 2017

Kerstin Walte

3

1 reference

Europe PubMed Central

3 November 2017

Wolfgang Von Schuetz

4

1 reference

Europe PubMed Central

3 November 2017

Mari-Anne Gall

5

1 reference

Europe PubMed Central

3 November 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

3 November 2017

full work available at URL

1 reference

Europe PubMed Central

3 November 2017

26

1 reference

Europe PubMed Central

3 November 2017

11

1 reference

Europe PubMed Central

3 November 2017

3087-3092

1 reference

Europe PubMed Central

3 November 2017

Diabetic angiopathy in children

1

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

2

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Clinical pharmacology of human insulin

3

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Hypoglycaemia and counterregulation during childhood.

4

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Variability of insulin absorption and insulin action

5

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Insulins today and beyond

6

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens

7

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

New insulins in the treatment of diabetes mellitus

8

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

The impact of the diabetes control and complications trial and humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes

9

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Experience with insulin analogues in children

10

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.

12

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo

13

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

14

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Albumin binding and time action of acylated insulins in various species

15

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304

16

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

17

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart

19

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes

23

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Both insulin sensitivity and insulin clearance in children and young adults with Type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age

24

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Nocturnal glucose control and free insulin levels in children with type 1 diabetes by use of the long-acting insulin HOE 901 as part of a three-injection regimen

25

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.

26

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Prevalence and consequences of nocturnal hypoglycemia among conventionally treated children with diabetes mellitus

27

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Severe hypoglycemia in children and adolescents with IDDM: frequency and associated factors

28

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus

29

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Nocturnal hypoglycemia in children and adolescents with insulin-dependent diabetes mellitus: prevalence and risk factors

30

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Predictors of acute complications in children with type 1 diabetes.

31

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Accuracy of injection site identification among children with insulin dependent diabetes mellitus: a comparison of traditional and new visual aids

32

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Insulin loss at the injection site in children with type 1 diabetes mellitus

33

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Lipohypertrophy in young patients with type 1 diabetes

34

1 reference

10.2337/DIACARE.26.11.3087

https://api.crossref.org/works/10.2337/DIACARE.26.11.3087

25 March 2024

Identifiers

10.2337/DIACARE.26.11.3087

1 reference

Europe PubMed Central

3 November 2017

1 reference

Europe PubMed Central

3 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42611726&oldid=2143374803"